House Bill, 89th Legislature, Regular Session (2025)
HB 3717
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Filed by Rep. Harris (R), Leach (R), Phelan (R), Orr (R), VanDeaver (R).
How far it got in 2025
Left House committee; never got a floor vote
Last official action May 12, 2025.
We keep a summary of each 2025 bill. Its full history, text, amendments, and votes are on Texas Legislature Online.